Completed
The Roundtable on Genomics and Precision Health and the Forum on Drug Discovery, Development, and Translation hosted a workshop on March 22, 2016 that assessed the current landscape of genomic-enabled drug discovery and development activities in industry, academia, and government, examined enabling partnerships and business models, and considered gaps and best practices in how data from populations could be collected with the goal of improving the drug discovery process.